The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease

Những quyển sách tương tự

• Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
  Bằng: Benjamin, Elfrida R, et al.
  Được phát hành: (2012)
• Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients
  Bằng: Young-Gqamana, Brandy, et al.
  Được phát hành: (2013)
• Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice
  Bằng: Durant, Brandon, et al.
  Được phát hành: (2011)
• The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease
  Bằng: Khanna, Richie, et al.
  Được phát hành: (2012)
• Coformulation of a Novel Human α-Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice
  Bằng: Xu, Su, et al.
  Được phát hành: (2015)